Johnson & Johnson looks to offload remaining Kenvue stake in $3.75B deal

After Johnson & Johnson's consumer healthcare spinoff last year—and its subsequent reduction in holdings in the new company—the healthcare conglomerate is once again cutting its stake in Kenvue.

This time, though, J&J plans to exit Kenvue completely.